Esophageal Irritation due to Alendronate Sodium Tablets (Possible Mechanisms)

Authors: Peter C.P.; Handt L.K.; Smith S.M.

Source: Digestive Diseases and Sciences, Volume 43, Number 9, 1 September 1998 , pp. 1998-2002(5)

Publisher: Springer

Key:

- Free Content

- New Content

- Subscribed Content

- Free Trial Content

Abstract:

Animal studies were done using an in vivo dog model to examine the possible mechanism for the esophageal adverse events reported with alendronate sodium tablets. These studies showed that under low pH conditions alendronate sodium can cause esophageal irritation. No esophageal irritation occurred at pH 3.5 or higher where the drug exists primarily as the sodium salt. The animal studies also showed that alendronate sodium can exacerbate preexisting esophageal damage. Exposure of the esophageal mucosa for a prolonged period to alendronate sodium tablet can also cause mild esophageal irritation. These findings suggest that the esophageal irritation in patients taking Fosamax can be from prolonged contact with the tablet, reflux of acidic gastric contents with alendronate sodium, and exacerbation of preexisting esophageal damage. The findings also suggest that other bisphosphonates can cause esophageal injury under similar conditions.

Keywords: BISPHOSPHONATE; GASTROINTESTINAL IRRITATION

Language: English

Document Type: Regular paper

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$47.00 plus tax Refund Policy